30/09/2014
Boehringer Ingelheim inaugurates its new ICT center
Boehringer Ingelheim inaugurates its new ICT center
The Boehringer Ingelheim pharmaceutical company inaugurated on September 26 its new ICT centre in Sant Cugat, next to the Barcelona Synchrotron Park. Jointly with those in Buenos Aires and Singapore, this new centre aims at improving the efficiency of the multinational German company and optimizing service to its customers.
The Boehringer Ingelheim group is among the top 20 most important pharmaceutical companies in the world. Established in 1885, its head office is in Ingelheim, Germany, and it works on a global scale with 142 subsidiaries and 47,400 employees.
Established in Spain in 1952, Boehringer Ingelheim Spain is headquartered in Sant Cugat and currently employs next to 1,600 people and has two international production centres in Sant Cugat and Malgrat del Mar.
Information based on the news issued on the company’s Spanish website.
The Boehringer Ingelheim group is among the top 20 most important pharmaceutical companies in the world. Established in 1885, its head office is in Ingelheim, Germany, and it works on a global scale with 142 subsidiaries and 47,400 employees.
Established in Spain in 1952, Boehringer Ingelheim Spain is headquartered in Sant Cugat and currently employs next to 1,600 people and has two international production centres in Sant Cugat and Malgrat del Mar.
Information based on the news issued on the company’s Spanish website.
More news
28/01/2021
Institutional visit to the Elena Renewable Gas Plant in Parc de l'Alba
12/01/2021
2021: the Alba synchrotron begins its mutation
30/12/2020
The Park has a new Urban Development Master Plan
29/11/2020
The director of Parc de l'Alba, Pere Solà, academic director of the new Postgraduate Course in Urban Planning and Health at the UPC School
18/11/2020
Catalan minister Ramon Tremosa visits the ALBA synchrotron and announces the creation of a public-private investment fund to improve knowledge transfer
03/11/2020
Catalonia, at the forefront of Europe in life sciences and health; the Alba synchrotron contributes to this leadership